Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$126.68
-2.72%
Mkt Cap $23.51B
Analyst Ratings
Buy
20
Hold
7
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
Implied Upside
-14.0%
Consensus $108.92 vs current $126.68
NASDAQ·Healthcare·Biotechnology
$126.68
-2.72%
Mkt Cap $23.51B
Buy
20
Hold
7
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
-14.0%
Consensus $108.92 vs current $126.68